Jeff Elleraas

688 total citations
10 papers, 261 citations indexed

About

Jeff Elleraas is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeff Elleraas has authored 10 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeff Elleraas's work include Catalytic C–H Functionalization Methods (2 papers), Synthesis and biological activity (2 papers) and Cancer therapeutics and mechanisms (2 papers). Jeff Elleraas is often cited by papers focused on Catalytic C–H Functionalization Methods (2 papers), Synthesis and biological activity (2 papers) and Cancer therapeutics and mechanisms (2 papers). Jeff Elleraas collaborates with scholars based in United States and China. Jeff Elleraas's co-authors include Michael R. Collins, Paul Richardson, Ted W. Johnson, Jason Ewanicki, Neal W. Sach, Gary M. Gallego, Chi He, Sajiv K. Nair, Matthew Del Bel and Jillian E. Spangler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and ACS Catalysis.

In The Last Decade

Jeff Elleraas

10 papers receiving 257 citations

Peers

Jeff Elleraas

OC

MB

CTM

PS

IC

David R. Cheshire United Kingdom

Michael A. Galella United States

Paul Eastwood Spain

Edward P. Vacek United States

Aneela Shah United Kingdom

Kenneth P. Spina United States

Kyle Clagg United States

Walíd Fathalla Egypt

Stanley N. S. Vasconcelos Brazil

Dominic P. Affron United Kingdom

David R. Cheshire United Kingdom

Jeff Elleraas

213 ×1.2

OC

102 ×1.2

MB

32 ×0.9

CTM

11 ×0.4

PS

15 ×0.6

IC

Citations per year, relative to Jeff Elleraas Jeff Elleraas (= 1×) peers David R. Cheshire

Countries citing papers authored by Jeff Elleraas

Since Specialization

Citations

This map shows the geographic impact of Jeff Elleraas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Elleraas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Elleraas more than expected).

Fields of papers citing papers by Jeff Elleraas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Elleraas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Elleraas. The network helps show where Jeff Elleraas may publish in the future.

Co-authorship network of co-authors of Jeff Elleraas

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Elleraas. A scholar is included among the top collaborators of Jeff Elleraas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Elleraas. Jeff Elleraas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Zhao, Jin‐Xin, Chi He, Benjamin J. Burke, et al.. (2021). 1,2-Difunctionalized bicyclo[1.1.1]pentanes: Long–sought-after mimetics for ortho / meta -substituted arenes. Proceedings of the National Academy of Sciences. 118(28). 101 indexed citations

2.

Denis, Tyler G. St., Nelson Y. S. Lam, Nikita Chekshin, et al.. (2021). Mechanistic Study of Enantioselective Pd-Catalyzed C(sp³)–H Activation of Thioethers Involving Two Distinct Stereomodels. ACS Catalysis. 11(15). 9738–9753. 22 indexed citations

3.

Elleraas, Jeff, Jason Ewanicki, Ted W. Johnson, et al.. (2016). Conformational Studies and Atropisomerism Kinetics of the ALK Clinical Candidate Lorlatinib (PF‐06463922) and Desmethyl Congeners. Angewandte Chemie. 128(11). 3654–3659. 7 indexed citations

4.

Elleraas, Jeff, Jason Ewanicki, Ted W. Johnson, et al.. (2016). Conformational Studies and Atropisomerism Kinetics of the ALK Clinical Candidate Lorlatinib (PF‐06463922) and Desmethyl Congeners. Angewandte Chemie International Edition. 55(11). 3590–3595. 40 indexed citations

5.

Guo, Chuangxing, Susan E. Kephart, Martha A. Ornelas, et al.. (2011). Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer. Bioorganic & Medicinal Chemistry Letters. 22(2). 1230–1236. 11 indexed citations

6.

Paderes, Genevieve, et al.. (2010). Structure-Based and Property-Compliant Library Design of 11β-HSD1 Adamantyl Amide Inhibitors. Methods in molecular biology. 685. 191–215. 1 indexed citations

7.

Huang, Buwen, Jeff Elleraas, K.S. Gajiwala, et al.. (2009). Solution-Phase Parallel Synthesis of Hsp90 Inhibitors. Journal of Combinatorial Chemistry. 11(5). 860–874. 10 indexed citations

8.

Kung, Pei‐Pei, Buwen Huang, Gang Zhang, et al.. (2009). Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone. Journal of Medicinal Chemistry. 53(1). 499–503. 64 indexed citations

9.

Liu, Zhengyu, et al.. (2009). (R)-N-Methyl-4-[2-(methylsulfanyl)pyrimidin-4-yl]-1-(tetrahydrofuran-3-yl)-1H-pyrazol-5-amine. Acta Crystallographica Section E Structure Reports Online. 65(3). o616–o616. 3 indexed citations

10.

Liu, Zhengyu, et al.. (2009). (R)-4-[2-(Methylsulfanyl)pyrimidin-4-yl]-1-(tetrahydrofuran-3-yl)-1H-pyrazol-5-amine. Acta Crystallographica Section E Structure Reports Online. 65(4). o697–o697. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact